Test of a Homeopathic Dilution of Aconitum napellus A Clinical, Randomized, Double-Blind, Controlled Crossover Study in Healthy Volunteers

被引:6
作者
Piltan, Daryoush [1 ]
Rist, Lukas [1 ]
Simoes-Wuest, A. Paula [1 ]
Saller, Reinhard [2 ]
机构
[1] Paracelsus Hosp, Res Dept, CH-8805 Richterswil, Switzerland
[2] Univ Zurich Hosp, Inst Complementary Med, Dept Internal Med, Zurich, Switzerland
来源
FORSCHENDE KOMPLEMENTARMEDIZIN | 2009年 / 16卷 / 03期
关键词
Homeopathic potencies; Aconitum napellus; Randomized trial; Crossover study; Placebo; Humans; PROSTATE-CANCER GROWTH; PLACEBO; TRIALS; METAANALYSIS; POTENCIES;
D O I
10.1159/000219316
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Although healthy persons often report on reactions to homeopathically diluted substances, the mechanism behind such reactions remains unclear. This study examines whether a distinction can be made between the short-term reactions of healthy volunteers to a homeopathically diluted substance-Aconitum napellus C30 - and to a placebo. Participants and Methods: From the 33 subjects randomized for this double-blind, placebo-controlled crossover study, 27 could be included in the analysis. The study comprised two 7-day-long treatment periods, each including the intake of a study preparation for 3 days and a wash-out period of 4 days. One group was first treated with Aconitum napellus C30 and then with placebo; the other group received the two study preparations in the reverse order. The signs and symptoms before the first treatment and after each treatment were collected, evaluated, weighted and repertorized. Based on this classification the blinded physician assessed these signs and symptoms as study outcome parameter to represent the responses to each of the study preparations. Statistical analysis of the data was performed using the Wilcoxon-Mann-Whitney rank test. Results: Crossover differences yielded statistical significance between the classified reactions towards Aconitum napellus C30 and to placebo (p = 0.004). Conclusions: A clear difference between the reported short-term reactions of healthy subjects towards Aconitum napellus C30 and towards placebo was shown. The crossover design with intra-individual comparisons proved to be adequate to recognize the study preparations and for the statistical analysis of a small population sample.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 50 条
  • [1] The effects of homeopathic belladonna 30CH in healthy volunteers -: a randomized, double-blind experiment
    Walach, H
    Köster, H
    Hennig, T
    Haag, G
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2001, 50 (03) : 155 - 160
  • [2] Effect of chlorogenic acids on fatigue and sleep in healthy males: A randomized, double-blind, placebo-controlled, crossover study
    Ochiai, Ryuji
    Tomonobu, Kazuichi
    Ikushima, Ippei
    FOOD SCIENCE & NUTRITION, 2018, 6 (08): : 2530 - 2536
  • [3] Efficacy of Individualized Homeopathic Medicines in Plantar Fasciitis: Double-blind, Randomized, Placebo-Controlled Clinical Trial
    Shahid, Sana
    Ghosh, Shubhamoy
    Chakrabortyl, Ardhendu Shekhar
    Maiti, Shukdeb
    Sadhukhan, Satarupa
    Koley, Munmun
    Saha, Subhranil
    HOMEOPATHY, 2022, 111 (01) : 22 - 30
  • [4] Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study
    Zhang, Ting
    Tao, Yi
    Pu, Junliang
    Zhu, Mingxue
    Wan, Lei
    Tang, Chengyong
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [5] A double-blind, randomized, homeopathic pathogenetic trial with healthy persons:: Comparing two high potencies
    Möllinger, H
    Schneider, R
    Löffel, M
    Walach, H
    FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE, 2004, 11 (05): : 274 - 280
  • [6] Individualized Homeopathic Medicines as Adjunctive Treatment of Pediatric Epilepsy: A Double-Blind, Randomized, Placebo-Controlled Trial
    Gupta, Bharti
    Misra, Pankhuri
    Karuppusamy, Avaranjika
    Balamurugan, Dharshna
    Parewa, Maneet
    Tomar, Maneela
    Rai, Shruti
    Vashishth, Himani
    Sadhukhan, Satarupa
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    HOMEOPATHY, 2023, 112 (03) : 170 - 183
  • [7] Individualized Homeopathic Medicines in Treatment of Vitiligo: Double-Blind, Randomized, Placebo-Controlled Pilot Trial
    Karuppusamy, Avaranjika
    Paul, Swapan
    Chattopadhyay, Abhijit
    Balamurugan, Dharshna
    Malathi, Maria
    Kumar, Ashwani
    Suchiang, Eiphrangdaka Lyngdoh
    Sadhukhan, Satarupa
    Koley, Munmun
    Saha, Subhranil
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2022, 28 (01): : 96 - 102
  • [8] Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
    Laskar, Bakibillah
    Paul, Swapan
    Chattopadhyay, Abhijit
    Karuppusamy, Avaranjika
    Balamurugan, Dharshna
    Bhakta, Puja
    Das, Sourav
    Pal, Siddhartha
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    HOMEOPATHY, 2023, 112 (02) : 74 - 84
  • [9] Individualized Homeopathic Medicines in the Treatment of Psoriasis Vulgaris: Double-Blind, Randomized, Placebo-Controlled Trial
    Balamurugan, Dharshna
    Nayak, Chintamani
    Chattopadhyay, Abhijit
    Karuppusamy, Avaranjika
    Ambrose, Maria Malathi
    Kumar, Ashwani
    Singh, Navin Kumar
    Koley, Munmun
    Saha, Subhranil
    COMPLEMENTARY MEDICINE RESEARCH, 2023, 30 (04) : 317 - 331
  • [10] Individualized homeopathic medicines in the treatment of premenstrual syndrome: A double-blind, randomized, placebo-controlled trial
    Sahoo, Sanjib
    Nayak, Chintamani
    Rath, Prasanta
    Bhattacharya, Soumya
    Mukherjee, Suranjana
    Dutta, Abhijit
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (06)